P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION

• Aleksandar Savic,
• Adele Taylor,
• Jovanka Ilic,
• Pierre Fenaux,
• Argiris Symeonidis,
• Catherine Cargo,
• Moshe Mittelman,
• Reinhard Stauder,
• Guillermo Sanz,
• Jaroslav Čermák,
• Saskia Langemeijer,
• Eva Hellström-Lindberg,
• Raphael Itzykson,
• Agnes Guerci-Bresler,
• Dominic Culligan,
• Ioannis Kotsianidis,
• Panagiotis Panagiotidis,
• Corine van Marrewijk,
• Alexandra Smith,
• Simon Crouch,
• Theo de Witte,
• Luca Malcovati

Affiliations

Aleksandar Savic

1 Clinic of Hematology, Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Adele Taylor

2 Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom

Jovanka Ilic

1 Clinic of Hematology, Clinical Center of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Pierre Fenaux

3 Service d’Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris, France

Argiris Symeonidis

4 Dep. of Medicine, Div. Hematology, University of Patras Medical School, Patras, Greece

Catherine Cargo

5 Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, St James’s University Hospital & Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Moshe Mittelman

6 Dep. of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel

Reinhard Stauder

7 Dep. of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck, Austria

Guillermo Sanz

8 Dep. of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain, Scientific Director, Health Research Institute La Fe, Valencia, Spain, and CIBERONC, ISCIII, Madrid, Spain

Jaroslav Čermák

9 Dep. of Clinical Hematology, Inst. of Hematology & Blood Transfusion, Praha, Czech Republic

Saskia Langemeijer

10 Dep. of Hematology, Radboud university medical center, Nijmegen, The Netherlands

Eva Hellström-Lindberg

11 Dep. of Medicine, Div. Hematology, Karolinska Institutet, Stockholm, Sweden

Raphael Itzykson

3 Service d’Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris, France

Agnes Guerci-Bresler

12 Service d’Hématologie, Centre Hospitalier Universitaire Brabois Vandoeuvre, Nancy, France

Dominic Culligan

13 Dep. of Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

Ioannis Kotsianidis

14 Dep. of Hematology, Democritus University of Thrace Medical School, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Panagiotis Panagiotidis

15 Dep. of Haematology, 1st Dep. of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Medical School, Laikon General Hospital, Athens, Greece

Corine van Marrewijk

10 Dep. of Hematology, Radboud university medical center, Nijmegen, The Netherlands

Alexandra Smith

2 Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom

Simon Crouch

2 Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom

Theo de Witte

16 Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands

Luca Malcovati

17 Dep. of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy